![Neil Brewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Brewis
Directeur Technique/Scientifique/R&D chez
F-star Alpha Ltd.
Profil
Neil Brewis is currently Director at F-star Therapeutics Ltd. and Chief Scientific Officer at F-star Alpha Ltd. since 2015.
Former roles include Head-Research at Domantis Ltd. from 2002 to 2007, Vice President & Head-Biopharmaceuticals Research at GSK Plc from 2007 to 2015, Chief Scientific Officer at F-star Therapeutics, Inc. (United States), and Chief Scientific Officer at F-star Therapeutics, Inc. from 2020 to 2023.
Education includes a doctorate from the University Of Dundee and an undergraduate degree from the University of Hertfordshire.
Postes actifs de Neil Brewis
| Sociétés | Poste | Début |
|---|---|---|
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Directeur Technique/Scientifique/R&D | 02/11/2015 |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Directeur/Membre du Conseil | - |
Anciens postes connus de Neil Brewis
| Sociétés | Poste | Fin |
|---|---|---|
| F-STAR THERAPEUTICS, INC. | Directeur Général | - |
| GSK PLC | Corporate Officer/Principal | 01/10/2015 |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Directeur Technique/Scientifique/R&D | 01/01/2007 |
| SPRING BANK PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Neil Brewis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hertfordshire
 University of Hertfordshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Health Technology |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
